Department of Neurology, West China Hospital, Sichuan University, Guo Xuexiang #37, Chengdu, 610041, China.
J Mol Neurosci. 2019 Mar;67(3):467-471. doi: 10.1007/s12031-018-1254-4. Epub 2019 Jan 30.
Cerebral cavernous malformation (CCM) is a congenital vascular anomaly that predominantly involves the central nervous system (CNS). CCM occurs in either a sporadic or an inherited form; the latter is called familial cerebral cavernous malformation (FCCM). FCCM has an autosomal dominant transmission with incomplete penetrance and variable clinical expression that is associated with germline mutations in the CCM1/KRIT1, CCM2/MGC4607, and CCM3/PDCD10 genes. Herein, we disclose two novel heterozygous mutations in the CCM2 gene in a Chinese family: a deletion mutation (c.55C>T; p. R19X, 426) in exon 2 and a mutation (c.*18G>A) in the noncoding region of exon 10. Our findings provide new CCM2 gene mutation profiles and further evidence for phenotypic heterogeneity.
脑 钙 化 性 血 管 瘤 病 变(CCM)是一种先天的血管畸形,主要涉及中枢神经系统(CNS)。CCM 以散发性或遗传性形式发生;后者称为家族性脑钙 化 性 血 管 瘤 病(FCCM)。FCCM 呈常染色体显性遗传,不完全外显,临床表型多样,与 CCM1/KRIT1、CCM2/MGC4607 和 CCM3/PDCD10 基因中的种系突变有关。在此,我们在中国一个家庭中揭示了 CCM2 基因的两个新的杂合突变:第 2 外显子的缺失突变(c.55C>T;p.R19X,426)和第 10 外显子非编码区的突变(c.*18G>A)。我们的发现提供了新的 CCM2 基因突变谱,并进一步证明了表型异质性。